8 results
Pulmonary Nodule
Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
called lung masses ... associated with lung ... Management options ... , and surgical resection ... a diagnosis of lung
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... goals of assessing lung ... Effusions #MPE #Algorithm ... #Management #ATS
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
affecting the lungs ... inhibitors • Injection ... • Progressive lung ... tracheobronchial stenosis, malignancy ... TB #Diagnosis #Management
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Pearls: • IDA and active ... NRH & Heme eval. re ... ileal Crohn's/resection ... /other causes • ... #diagnosis #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
affecting the lungs ... inhibitors • Injection ... • Progressive lung ... tracheobronchial stenosis, malignancy ... TB #Diagnosis #Management
Polymyalgia Rheumatica (PMR) Diagnosis and Management Summary

WHAT?
 • Polymyalgia rheumatica (PMR) is a common systemic inflammatory
Diagnosis and Management ... disease of unknown cause ... with restricted active ... arthropathies, myositis, malignancy ... PMR #Diagnosis #Management
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... goals of assessing lung ... #Algorithm #Effusion ... #Malignant #Management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
effusion, INC risk PE ... and Arthritis Malignancy ... MALT Lymphoma • Lung ... muscarinic agonists • Active ... Rheumatology #Diagnosis #Management